Projected Surge in Veterinary Biologics Market: Estimated to Reach US$ 18.2 Billion by 2029

The global veterinary biologics market is estimated to be US$ 11.4 Bn in 2022 and is expected to reach US$ 18.2 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey. Veterinary Biologics Market Outlook: Data Points Market Insights Market Value 2021 USD 10.6 Bn Market Value 2029 USD 18.2 Bn CAGR 2022-2029 6.9% Key Players The key …

Ultrasound Systems Market to Grow at 5.5% CAGR during Forecast Period (2022-2028): Industry Analysis and Future Projections

The market for ultrasound systems is expected to reach USD 13.2 Billion by 2028, growing at a CAGR of 5.5% over the forecast period, from an estimated USD 9.5 Billion in 2022. (2022-2028). Digitization in the healthcare sector has revamped the ultrasound systems market. The advancements in different spheres of the industry has benefited not just …

Cold, Cough, and Sore Throat Remedies Market to Expand at 0.6% CAGR between 2022 and 2032: Valued at Approximately US$ 37.7 Billion by 2032

By the end of 2022, the market for cold, cough, and sore throat remedies is anticipated to be worth US$ 39.9 Billion. From 2022 to 2032, the market is projected to grow at a CAGR of 0.6%, reaching a valuation of US$ 37.7 Billion. Future Market Insights’ latest report delivers such discernments that are expected to …

Promising Outlook for the Neurovascular Stent Retrievers Market: Growth at a CAGR of 6.3%, Projected to Reach US$ 1243.57 Million by 2032

The Neurovascular Stent Retrievers Market is a segment of the medical devices industry that focuses on devices used in the treatment of ischemic stroke. Ischemic stroke occurs when a blood clot blocks an artery supplying blood to the brain, leading to a loss of blood flow and potentially causing brain damage. Neurovascular stent retrievers, also …

Future Prospects of Tamoxifen Market: Estimated Value of USD 687.44 Million by 2032 with a CAGR of 0.07%

The Tamoxifen Market is blocks the oestrogen receptor in breast tissue. This selective oestrogen receptor modulator is used to treat breast cancer. While operating as an antagonist in mammary tissue, tomoxifen acts as an agonist in the endometrium. Both men and women with metastatic breast cancer should take tamoxifen, according to medical advice. Additionally, ductal …

Disposable Surgical Drapes Sales Projected to Surge at 4.8% CAGR from 2023 to 2033, Reveals Future Market Insights

According to a recently released Future Market Insights study, the global Surgical Drapes Market is expected to generate sales of US$ 1.4 billion in 2022 and expand at a CAGR of 4.2% from 2023 to 2033. The market is anticipated to reach US$ 2.1 billion by the end of 2033. From 2023 to 2033, the …

Growing Demand for Retinal Vein Occlusion Treatment Drives Market to a Projected 5.9% CAGR till 2033, Reports Future Market Insights

The Retinal Vein Occlusion Treatment Market refers to the pharmaceuticals and medical devices used to manage and treat retinal vein occlusion, a condition where a vein in the retina becomes blocked or partially blocked. RVO can lead to vision loss or impairment if left untreated. There are two main types of retinal vein occlusion: central …

Future Market Insights Study Forecasts Nasal Polyposis Treatment Market to Grow at 6.7% CAGR Until 2033, Reaching US$ 8.8 billion

The Nasal Polyposis Treatment Market refers to the pharmaceutical and medical devices market dedicated to providing treatment options for nasal polyposis. Nasal polyposis is a chronic inflammatory condition characterized by the development of benign growths (polyps) in the nasal cavity and sinuses. These polyps can cause symptoms such as nasal congestion, loss of smell, facial …

Cell and Gene Therapy Manufacturing Market to Reach a Valuation of US$ 240 Billion by 2033 and grow with a CAGR of 29% over the forecast period | Future Market Insights, Inc.

The global Cell And Gene Therapy Manufacturing Market is anticipated to create phenomenal growth opportunities over the forecast period by registering a CAGR of 29% from 2023 to 2033. The global market reached a valuation of around US$ 15.6 Billion in 2022 and is expected to surpass a valuation of around US$ 240 Billion by …

Rise in Consumption of Salmon and Tilapia to drive the Aquaculture Vaccines Market, reaching US$ 913.6 Million by the year 2033 a CAGR of 8.5%

The global Aquaculture Vaccines Market is worth US$ 406 Million as of now and is expected to reach US$ 913.6 Million by the year 2033 at a CAGR of 8.5% between 2023 and 2033. Surge in aquaculture is the factor majorly driving the aquaculture vaccines market. There is an ever-increasing demand for canned fish products, …